Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (0QFP.IL) Stock

0QFP.IL logo

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

0QFP.ILHungary
Healthcare

Company profile

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. reported revenue of 928.96 billion HUF for fiscal year 2025, up 8.3% from fiscal year 2024, and net income of 232.34 billion HUF. That is a net profit margin of 25.0% for fiscal year 2025.

Figures from company filings; latest fiscal year ended December 31, 2025.

About Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. researches, develops, manufactures, markets, and sells pharmaceutical products worldwide. The company operates through two segments, Pharmaceuticals, and Wholesale and Retail. It develops and manufactures products in various therapeutic areas, including women's healthcare, cardiovascular, and central nervous system. The company offers women's healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids. It also provides central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and aesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic medicines, as well as products for the prevention and treatment of various cardiovascular diseases. In addition, the company produces various over-the-counter products for various health problems comprising Panangin for heart support; Escapelle and Postinor, an emergency contraceptive pill; Stopdiar and Nifuroxazide to treat diarrhea; RICHTER CycleBalance for infertility and PCOS; Curiosin for wound care; Groprinosin for antiviral and immunostimulant; Folik, a pregnancy supplement; Moilec for back and joint pain; Fasconal, a pain relief tablet; Lordestin for allergy; Magnezin, a magnesium supplement; Aflamil, an anti-inflammatory and antirheumatic cream; Oralsept, a sore throat and local anesthetic. Further, it provides financial and accounting, social and welfare, portfolio and project management, catering, carriage transportation, engineering, quality control, trading, asset management, and biotechnological services. Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. was founded in 1901 and is headquartered in Budapest, Hungary.

Leadership

  • Gabor Orban — CEO, Member of Exec. Board & Director, 44
  • Istvan Hamecz — CFO, Member of Exec. Board & Director, 56
  • Istvan Greiner — R&D Director and Member of Exec. Board, 63
  • Tibor Horvath — Commercial Director & Member of Exec. Board, 49
  • Katalin Erdei — HR Director & Member of Exec. Board, 49

How much revenue does Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. make?

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. reported 928.96 billion HUF in revenue for fiscal year 2025, up 8.3% from 857.55 billion HUF in fiscal year 2024.

What companies are similar to Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include UCB SA (0NZT.IL), Grifols, S.a. (0RDV.IL), Hikma Pharmaceuticals PLC (HIK.L), International Biotechnology Ord (IBT.L).

Company Information

SectorHealthcare
IndustryMulti-Therapeutic Drug Manufacturing
HeadquartersBudapest, Hungary
ExchangeIOB
TimezoneEurope/London (GMT)

Contact & Links

Address
Gyömroi út 19-21., Budapest, 1103
Phone
36 1 431 4000
Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.

Data as of .

How to cite: DataPorium, “Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (0QFP.IL)”, data as of Jun 30, 2026, https://dataporium.tech/stocks/0QFP.IL

LinkedInLinkedInXXYouTubeYouTube